Venture Capital Investments

Metagenex

Metagenex offers clinically confirmed solutions for the isolation of rare cells in the blood and other fluids. Its technology provides  the means of detecting circulating tumour cells for purposes of prognosis and the evaluation of patients' response to treatment, and the pre-natal diagnosis of genetic illnesses.